Skip to Content

A862 15 mg (Methylphenidate Hydrochloride Extended-Release 15 mg)

Pill with imprint A862 15 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 15 mg. It is supplied by Actavis Pharma, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for A862 15 mg

Methylphenidate hydrochloride extended-release 15 mg A862 15 mg

Methylphenidate Hydrochloride Extended-Release

Imprint
A862 15 mg
Strength
15 mg
Color
Yellow & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-3862

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.